Filtern
Erscheinungsjahr
- 2014 (2) (entfernen)
Schlagworte
- Kläranlage (1)
- Wastewater treatment plant (1)
Institut
- Chemie (2) (entfernen)
Recent studies have confirmed that the aquatic ecosystem is being polluted with an unknown cocktail of pharmaceuticals, their metabolites and/or their transformation products (TPs). Although individual pharmaceuticals are typically present at low concentrations, their continuous input into the aquatic ecosystem and their toxic and persistent presence are the major environmental concerns. Therefore, it is necessary to assess the environmental risk caused by these aquatic pollutants. Data on exposure are required for quantitative risk assessment of parent compounds and their transformation products (TPs) and/or metabolites. Such data are mostly missing, especially for TPs, because of the non-availability of TPs and very often metabolites for experimental testing. Therefore, the application of different in silico tools for qualitative risk assessment can be used. Also, the presence of these micro-pollutants (active pharmaceutical ingredients, APIs) in the aquatic cycle are increasingly seen as a challenge to the sustainable management of water resources worldwide due to ineffective effluent treatment and other measures for their input prevention. Given the poor prognosis for effluent treatment (‘end of the pipe’ approach) for input prevention of APIs in the environment, it is necessary to focus on the ‘beginning of the pipe’ strategy. The very beginning of the pipe is the molecules themselves. Therefore, novel approaches are needed like designing greener pharmaceuticals, i.e. better biodegradable ones in the aquatic environment after their release. Therefore, the present research work focused on two important topics a) assessment of the environmental risk associated with the presence of highly prescribed drugs and their TPs; b) demonstrating the feasibility of the ‘benign by design’ concept for designing biodegradable drug derivatives, which will have the better biodegradability in the environment after their release. The present thesis includes four research articles (1-4) which address these approaches. The first article is about the qualitative environmental risk assessment using the example of transformation products formed during photolysis (photo-TPs) of Diatrizoic acid (DIAT). Photolysis is the chemical reaction in which the compound is broken down by photons and often in combination with hydroxyl radicals. Photolysis is the most common abatement process of micro-pollutants in the environment. The qualitative risk assessment of DIAT and selected photo-TPs was performed by the PBT approach (i.e. Persistence, Bioaccumulation and Toxicity), using chemical analysis, experimental biodegradation test assays, QSAR models with several different toxicological endpoints and in silico read-across approaches. The second article addresses a tiered approach of implementing green and sustainable chemistry principles for theoretically designing better biodegradable and pharmacologically potent pharmaceuticals derivatives. Photodegradation process coupled with LC-MSn analysis, biodegradability testing and in silico tools such as quantitative structure-activity relationships (QSAR) analysis and molecular docking proved to be a very significant approach for the preliminary stages of designing chemical structures that would fit into the ´benign by design´ concept in the direction of green and sustainable pharmacy. Metoprolol (MTL) was used as an example. The third article was also the conceptual framework to get new drug derivatives that are biodegradable in order to tackle the global challenge of micro-pollutants in the aquatic cycle. This study increased the knowledge about the role of the attachment of certain functionalities to the parent drug molecule for its biodegradability whilst conserving drug-likeness. This approach was in the past a totally neglected issue within drug development. Atenolol (ATL), a selective β1 blocker, was selected as an example to incorporate the additional attribute such as biodegradability into its molecular structure while conserving its substructures responsible for β adrenergic receptor blocker activity. In fourth article, the concept of designing green biodegradable pharmaceuticals has been proven through expanded experimental analysis setting out from the experiences collected as described in article two and three. This study could be considered as a more extensive feasibility study of rational design of green drug derivatives. The non-selective β-blocker Propranolol (PPL) was used as an example. The risk assessment study (Article #1) contributes in enhancing the existing knowledge about the life cycle and behavior (fate) of pharmaceuticals with a special focus on photo-TPs which are generally formed during advanced effluent treatment and enter as such into the environment. Based on the obtained results, the application of the in silico tools for qualitative risk assessment analysis increased knowledge space about the environmental fate of TPs in case of their non-availability for experimental testing. The benign by design studies (Article #2-4) were based on the knowledge and experience collected during the work on DIAT. It demonstrated the feasibility of a novel approach of designing comparatively better degradable and pharmacological potent derivatives through the implementation of ´green chemistry´ principles. However, the present approach is in the juvenile stage and further knowledge has to be collected beforehand for the full implementation of this approach into drug development.
Perfluoroalkyl and polyfluoroalkyl substances (PFASs) have been widely used since 1950 in various consumer products as well as in industrial applications owing to their unique properties, e.g. being hydrophobic and lipophobic at the same time. Nowadays, some of these persistent and man-made PFASs can ubiquitously be found in humans, wildlife and various environmental media. One prominent representative of concern, belonging to the subgroup of perfluorocarboxylates (PFCs) and their conjugate acids (PFCAs), is perfluorooctanoat (PFO) and its conjugate acid (PFOA). Because of its adverse effects on human health and its persistency in the environment industry has started to replace PFO(A) and related long chain chemicals (with seven and more fully fluorinated carbon atoms) with so-called short chain PFASs (less than seven fully fluorinated carbon atoms), including precursors of PFC(A)s. Also these short chain PFC(A)s are persistent and can already be found in humans, ground- and drinking water and in remote regions. However, knowledge gaps exist in understanding the partitioning and the resulting mobility of short chain PFC(A)s in the environment. This is due to the fact that partitioning data of PFC(A)s from standardised experiments can easily be biased by various artefacts, e.g. self-aggregation of the molecules. Therefore, the objectives of this thesis are (i) to quantify the partitioning of PFC(A)s into mobile environmental media, (ii) to show how results from non-standard tests can be used to assess substance properties of concern and (iii) to conclude on whether the environmental exposure to short chain PFC(A)s is of concern from a regulatory point of view. In the first part of this thesis, the environmental mobility of short chain C4-7-PFC(A)s was investigated by quantifying their partitioning under non-standardised semi-environmental conditions into mobile environmental media, focusing on water and air, and comparing it to long chain PFC(A)s. Results are: Partitioning between water and particles in the aeration tank, primary and secondary clarifier of a wastewater treatment plant (WWTP) showed no distinct differences for short chain PFC(A)s compared to their long chain homologues (Paper 1). In a water-saturated sandy sediment column short chain PFC(A)s were not retarded, whereas long chain homologues were retarded by sorption to the sediment (Paper 2). Atmospheric particle-gas partitioning showed a lower fraction sorbed to particles for short chain PFC(A)s compared to long chain ones in samples from a WWTP (Paper 3). Air-water concentration ratios based on samples from the tanks of a WWTP were found to be higher for short chain PFC(A)s compared to long chain PFC(A)s (Paper 1). Additionally, in a newly developed experimental set-up the water to air transfer was used to derive that the pKa of C4-11-PFCAs must be <1.6 instead of up to 3.8 as reported in the literature (Paper 4). Overall, in the investigated systems short chain PFC(A)s showed a higher mobility due to a more pronounced partitioning into mobile environmental media compared to long chain PFC(A)s. In the second part of the thesis it was shown how PFO(A) - owing to its persistent, bioaccumulative and toxic (PBT-)properties – was in the context of this thesis successfully assessed as a substance of very high concern according to the criteria of the European REACH Regulation (EC No 1907/2006) by using data from non-standard tests (Paper 5). In conclusion, based on the knowledge of the high environmental mobility of short chain PFC(A)s and taking into account the argumentation of the PBT-concern of PFO(A), environmental exposure to short chain PFC(A)s is of concern and existing knowledge is already sufficient to initiate measures to prevent emissions of short chain PFC(A)s and their precursors into the environment.